Rare diseases
Investigational molecules
Locations
Study on the Effects and Safety of Dupilumab for Children Aged 2 to Under 6 with Uncontrolled Asthma or Severe Asthmatic Wheeze
CzechiaStudy on the Safety and Effects of Ocrelizumab for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis
ItalyStudy of Naxitamab and Sargramostim for High-Risk Neuroblastoma in Patients with Refractory Bone or Bone Marrow Disease
DenmarkStudy on the Safety and Effectiveness of Mirabegron for Children Aged 6 Months to Under 3 Years with Neurogenic Detrusor Overactivity
BelgiumStudy on the Safety and Effects of Risdiplam for Adults and Children with Spinal Muscular Atrophy
BelgiumStudy on the Safety and Effects of ARO-C3 for Adults with Complement-Mediated Kidney Disease
GermanyStudy on the Effect of a New Moisturiser with Glycerol and Urea on Skin Barrier in Adults with Atopic Dermatitis
GermanyStudy on Abemaciclib with Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer at Intermediate to High Risk
GermanyStudy of Venglustat and Imiglucerase for Adult Patients with Gaucher Disease TYPE 3
GermanyStudy on Ulcerative Colitis: Effects of Filgotinib and Gallium (68Ga) Chloride in Patients with Intestinal Fibrosis
The NetherlandsStudy on Ilofotase Alfa to Prevent Kidney Damage in Patients Undergoing Open Heart Surgery
BelgiumStudy of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
